Search
Filter Results
- Resource Type
- Article1
- Book1
- Book Digital1
- Article Type
- Review1
- Clinical Trial1
- Clinical Study1
- Comparative Study1
- Result From
- Lane Catalog1
- PubMed1
-
Year
- Journal Title
- Surg Clin North Am1
Search Results
Sort by
- BookAmerican Association of Clinical Care Nurses ; editors, Julie Miller, BSN, RN, CCRN-K and Mary Stahl, MSN, RN, CCNS, CCRN-K.Digital Access ClinicalKey Nursing 2018
- ArticleReimer RR.Surg Clin North Am. 1978 Aug;58(4):843-9.Several chemotherapeutic agents given singly or in combination are capable of producing significant tumor regression in recurrent breast cancer. Such remissions improve both the quality and duration of life. To date, the most active combinations have been variations of Cooper's CMFVP therapy or regimens containing Adriamycin. Further improvements in survival may be realized from the addition of hormonal and/or immune therapy to these active combinations as well as from the development of new drugs.